NM_000051.4:c.*548G>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000051.4(ATM):​c.*548G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.522 in 171,628 control chromosomes in the GnomAD database, including 24,383 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 21088 hom., cov: 26)
Exomes 𝑓: 0.51 ( 3295 hom. )

Consequence

ATM
NM_000051.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.02

Publications

25 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 11-108366056-G-T is Benign according to our data. Variant chr11-108366056-G-T is described in ClinVar as Benign. ClinVar VariationId is 302265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.631 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.*548G>T
3_prime_UTR
Exon 63 of 63NP_000042.3
ATM
NM_001351834.2
c.*548G>T
3_prime_UTR
Exon 64 of 64NP_001338763.1
C11orf65
NM_001330368.2
c.640+19864C>A
intron
N/ANP_001317297.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.*548G>T
3_prime_UTR
Exon 63 of 63ENSP00000501606.1
ATM
ENST00000452508.7
TSL:1
c.*548G>T
3_prime_UTR
Exon 64 of 64ENSP00000388058.2
C11orf65
ENST00000615746.4
TSL:1
c.*2-9947C>A
intron
N/AENSP00000483537.1

Frequencies

GnomAD3 genomes
AF:
0.523
AC:
77368
AN:
147952
Hom.:
21084
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.370
Gnomad AMI
AF:
0.643
Gnomad AMR
AF:
0.614
Gnomad ASJ
AF:
0.641
Gnomad EAS
AF:
0.432
Gnomad SAS
AF:
0.649
Gnomad FIN
AF:
0.625
Gnomad MID
AF:
0.735
Gnomad NFE
AF:
0.569
Gnomad OTH
AF:
0.558
GnomAD4 exome
AF:
0.515
AC:
12156
AN:
23614
Hom.:
3295
Cov.:
0
AF XY:
0.518
AC XY:
5627
AN XY:
10872
show subpopulations
African (AFR)
AF:
0.358
AC:
327
AN:
914
American (AMR)
AF:
0.529
AC:
294
AN:
556
Ashkenazi Jewish (ASJ)
AF:
0.584
AC:
779
AN:
1334
East Asian (EAS)
AF:
0.460
AC:
2280
AN:
4952
South Asian (SAS)
AF:
0.580
AC:
130
AN:
224
European-Finnish (FIN)
AF:
0.389
AC:
7
AN:
18
Middle Eastern (MID)
AF:
0.682
AC:
90
AN:
132
European-Non Finnish (NFE)
AF:
0.538
AC:
7320
AN:
13610
Other (OTH)
AF:
0.496
AC:
929
AN:
1874
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
243
486
730
973
1216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.523
AC:
77377
AN:
148014
Hom.:
21088
Cov.:
26
AF XY:
0.531
AC XY:
38037
AN XY:
71670
show subpopulations
African (AFR)
AF:
0.370
AC:
14890
AN:
40280
American (AMR)
AF:
0.614
AC:
9009
AN:
14678
Ashkenazi Jewish (ASJ)
AF:
0.641
AC:
2217
AN:
3458
East Asian (EAS)
AF:
0.432
AC:
2152
AN:
4980
South Asian (SAS)
AF:
0.650
AC:
3080
AN:
4740
European-Finnish (FIN)
AF:
0.625
AC:
5685
AN:
9096
Middle Eastern (MID)
AF:
0.723
AC:
204
AN:
282
European-Non Finnish (NFE)
AF:
0.569
AC:
38406
AN:
67536
Other (OTH)
AF:
0.559
AC:
1150
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1700
3399
5099
6798
8498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
682
1364
2046
2728
3410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.400
Hom.:
1270
Bravo
AF:
0.513
Asia WGS
AF:
0.566
AC:
1970
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ataxia-telangiectasia syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.093
DANN
Benign
0.36
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs227092; hg19: chr11-108236783; API